Icon

NUZOLVENCE (NDA219491)- (3GM/PACKET)

ZOLIFLODACIN ENTASIS THERAP
3GM/PACKET
No No
2034-Jan-21 2030-Dec-12
None None
None No
NUZOLVENCE is a spiropyrimidinetrione bacterial type II topoisomerase inhibitor indicated for the treatment of uncomplicated urogenital gonorrhea due to Neisseria gonorrhoeae in adults and pediatric patients 12 years of age and older, weighing at least 35 kg.
0 0 0
Total Other Developers None
Drugs with Suitability No
3GM/PACKET ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.